These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6601787)

  • 1. [The effect of hemodialysis on antibody-dependent and natural cytotoxicity in uremic patients].
    Láng I; Taraba I; Hering A
    Orv Hetil; 1983 Mar; 124(10):559-62. PubMed ID: 6601787
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
    Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
    Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of cyclosporin A on the antibody-dependent and natural cytoxicity of human lymphocytes].
    Láng I; Chen SH; Peter L
    Orv Hetil; 1983 May; 124(20):1181-3. PubMed ID: 6602965
    [No Abstract]   [Full Text] [Related]  

  • 10. Depressed polymorphonuclear leukocyte functions associated with normal cytotoxic functions of T and natural killer cells during chronic hemodialysis.
    Charpentier B; Lang P; Martin B; Noury J; Mathieu D; Fries D
    Clin Nephrol; 1983 Jun; 19(6):288-94. PubMed ID: 6603319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological findings in kidney insufficiency with and without hemodialysis. II. K cell activity under chronic hemodialysis conditions].
    Varga A; Stosiek P; Lincke HU
    Z Urol Nephrol; 1980 May; 73(5):367-71. PubMed ID: 7456804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell mediated immune reactivity in hemodialysis patients.
    Plavljanic D; Molnar V; Vitale B; Benkovic B
    Minerva Nefrol; 1979; 26(2):169-72. PubMed ID: 471343
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic studies in uremia].
    Dall'Aglio P; Chizzolini C; Brigati C; Ghiringhelli P
    Minerva Nefrol; 1983; 30(2 Suppl):19-26. PubMed ID: 6602955
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance.
    Krawczyk W; Marczewski K; Ledwozyw A
    Clin Nephrol; 1995 Nov; 44(5):340. PubMed ID: 8605718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of heparin in uremic patients during hemodialysis].
    Cullmann W; Glöckner WM; Müller N
    Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
    Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
    Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
    Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased antibody-dependent and spontaneous cell-mediated cytotoxicity in patients with chronic renal failure.
    Láng I; Taraba I; Petrányi G
    Immunol Lett; 1981 Nov; 3(5):267-71. PubMed ID: 7327620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.